What is Beam Therapeutics's short- term investments?

Beam Therapeutics (BEAM) reported short- term investments of $923.36M in Q1 2026.

How has Beam Therapeutics's short- term investments changed year-over-year?

Beam Therapeutics's short- term investments increased by 33.4% year-over-year, from $692.05M to $923.36M.

What is the long-term trend for Beam Therapeutics's short- term investments?

Over 3 years (2022 to 2025), Beam Therapeutics's short- term investments has grown at a 4.0% compound annual growth rate (CAGR), from $845.37M to $950.27M.

Beam Therapeutics BEAM Short- term Investments

Short- term Investments at other companies

Vertex PharmaceuticalsVRTX

——

Intellia TherapeuticsNTLA

——

CRISPR TherapeuticsCRSP

——

Disc MedicineIRON

——

PTC TherapeuticsPTCT

——

Protagonist TherapeuticsPTGX

——

Other financials

Income statement

See full

Revenue$31.7M+325%

Operating income-$107.2M+10.1%

Net income-$94.3M+12.9%

EPS (diluted)-$0.91+26.0%

Balance sheet

See full

Cash & equivalents$288.3M-45.4%

Total debt$250.8M+58.6%

Total equity$1.2B+3.1%

Total assets$1.5B+0.9%

Cash flow

See full

Operating cash flow-$128.5M-23.7%

CapEx$2.2M-27.2%

Free cash flow-$130.7M-22.2%

Valuation

See full

Market cap$3.42B+24.5%

Profitability

See full

Operating margin-226.6%-90.5pp

Net margin-742.7%—

FCF margin-234%-86.6pp

Returns & leverage

See full

Return on equity-47.1%—

Debt / equity0.2×+0.1×

Current ratio17×+8.2×

Where this comes from

Reported directly by Beam Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.

The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Beam Therapeutics's short- term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Beam Therapeutics's short- term investments?: Beam Therapeutics (BEAM) reported short- term investments of $923.36M in Q1 2026.
How has Beam Therapeutics's short- term investments changed year-over-year?: Beam Therapeutics's short- term investments increased by 33.4% year-over-year, from $692.05M to $923.36M.
What is the long-term trend for Beam Therapeutics's short- term investments?: Over 3 years (2022 to 2025), Beam Therapeutics's short- term investments has grown at a 4.0% compound annual growth rate (CAGR), from $845.37M to $950.27M.